Patent details
EP3538221 Title: PEDIATRIC HUMAN DOSING OF THE ANTI-CD30 ANTIBODY-DRUG CONJUGATE BRENTUXIMAB VEDOTIN
Basic Information
- Publication number:
- EP3538221
- PCT Application Number:
- US2017061294
- Type:
- European Patent Granted for LU
- Legal Status:
- Lapsed
- Application number:
- EP178082707
- PCT Publication Number:
- WO2018089890
- First applicant's nationality:
- Translation Language:
- EPO Publication Language:
- English
- English Title of Invention:
- PEDIATRIC HUMAN DOSING OF THE ANTI-CD30 ANTIBODY-DRUG CONJUGATE BRENTUXIMAB VEDOTIN
- French Title of Invention:
- DOSAGE PÉDIATRIQUE DU CONJUGUÉ ANTICORPS ANTI-CD30-MÉDICAMENT BRENTUXIMAB VEDOTIN
- German Title of Invention:
- PEDIATRISCHE MENSCHLICHE DOSIERUNG FÜR ANTI-CD30 ANTIKÖRPERS-ARZNEIMITTEL KONJUGATE BRENTUXIMAB VEDOTIN
- SPC Number:
Dates
- Filing date:
- 13/11/2017
- Grant date:
- 09/10/2024
- EP Publication Date:
- 18/09/2019
- PCT Publication Date:
- 17/05/2018
- Claims Translation Received Date:
- Translations Received Date (B1 EP Publication):
- Translations Received Date (B2 EP Publication):
- Translations Received Date (B3 EP Publication):
- Publication date:
- 09/10/2024
- EP B1 Publication Date:
- 09/10/2024
- EP B2 Publication Date:
- EP B3 Publication Date:
- Lapsed date:
- 13/11/2024
- Expiration date:
- 13/11/2037
- Renunciation date:
- Revocation date:
- Annulment date:
Owner
- From:
- 02/10/2024
- Name:
- Takeda Pharmaceutical Company Limited
- Address:
- 1-1, Doshomachi 4-chome, Chuo-ku,, Osaka-shi, Osaka, Japan (JP)
Inventor
- Name:
- FASANMADE, Adedigbo
- Address:
- United States (US)
Priority
- Priority Number:
- 201662421527 P
- Priority Date:
- 14/11/2016
- Priority Country:
- United States (US)
Classification
- IPC classification:
- A61K 39/395; A61P 35/00; A61K 31/475; A61K 31/573; A61K 31/655; A61K 31/675; A61K 31/704; A61K 45/06; A61K 47/68;
Publication
European Patent Bulletin
- Issue number:
- 202441
- Publication date:
- 09/10/2024
- Description:
- Grant (B1)
Annual Fees
- Annual Fee Due Date:
- Annual Fee Number:
- Expected Payer:
- Last Annual Fee Payment Date:
- Last Annual Fee Paid Number:
- Payer:
| Filing date | Document type | Number of pages |
|---|